FMP
NASDAQ
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.
9.8 USD
0.1098 (1.12%)
Valuation Date:
Apr 26, 2024 4:00 PM
Share Price on Valuation Date
$9.8
Stock Beta
1.19
Shares Outstanding
10677444